Vertex secures European approval for CRISPR cell therapy
Now conditionally approved in Europe for sickle cell disease and…
Now conditionally approved in Europe for sickle cell disease and transfusion-dependent beta thalassemia, the CRISPR therapy offers eligible patients a functional cure.